Evidence map›Paper›PMID 32368293›Full record

ArticleJournal of Cancer2020

microRNA Expression Profiling in Young Prostate Cancer Patients.

Vladimir A Valera, Rafael Parra-Medina, Beatriz A Walter, Peter Pinto, Maria J Merino

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vladimir A ValeraUrologic Oncology Branch, National Cancer Institute, National Institutes of Health. Bethesda MD.
Rafael Parra-MedinaTranslational Surgical Pathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda MD.
Beatriz A WalterTranslational Surgical Pathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda MD.
Peter PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health. Bethesda MD.
Maria J MerinoTranslational Surgical Pathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda MD.
Universidad del Rosario · CO

Funding

Translational Surgical PathologyZIESC000853 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI MERINO, MARIA · 2009 to 2025
$4.3M
microRNA Profiling in the Spectrum of Kidney TumorsZIABC011405 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MERINO, MARIA · 2011 to 2025
$2.9M
miRNA profiling of prostate cancer in young and older male patientsZIABC011406 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MERINO, MARIA · 2011 to 2023
$1.8M
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small, non-coding RNA molecules with multiple roles in many biological processes. Few studies have shown the molecular characteristics in younger prostate cancer (PCa) patients. In this study, we performed miRNA profiling in young PCa (EO-PCa) cases compared with PCa arising in older men (LO-PCa).

Indexed as

early onsetMicroRNAsprostateyoung

Identifiers

PMID32368293
PMCPMC7196262
OpenAlexW3015712380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.